Osiris sets up division for biotech devices

08/5/2009 | American City Business Journals

Osiris Therapeutics established a biosurgery unit that focuses on developing and commercializing biotech devices for orthopedic procedures. The division comprises doctors, scientists, and regulatory and manufacturing experts who developed Osteocel, a line of medical devices sold by Osiris to NuVasive for $85 million.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX